Biosimilars Insights
Size the opportunity in this lucrative market and evaluate the disruptive effects biosimilars are having on the pharma industry
- Assess the current and future market size for biosimilars across six therapy areas
- Evaluate the global biosimilar pipeline and launch timing in major markets
- Track how payers and physicians respond to launches of biosimilars and understand the factors that will drive or limit use
- Review case study examples of successful corporate strategies deployed in the biosimilars space
